September 29, 2025

Vertex Pharmaceuticals (VRTX) Stock Analysis: Evaluating Growth Potential with a 24% Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to be a compelling prospect for investors seeking growth in the biotechnology sector. With a market capitalization of $98.9 billion,..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 21.65% Potential Upside with a Robust Dividend Yield

Pfizer, Inc. (PFE), a stalwart in the healthcare sector, continues to command investor attention with its significant market presence and promising financial indicators. With a market..

Sanofi (SNY) Stock Analysis: Unpacking a 35% Upside Potential for Investors

Sanofi (SNY), a behemoth in the healthcare sector, particularly in the drug manufacturing industry, continues to be a cornerstone for investors seeking stable growth and substantial..

Veeva Systems Inc. (VEEV) Stock Analysis: Unveiling a Potential 9.11% Upside for Investors

Investors focusing on the healthcare technology space might want to turn their attention to Veeva Systems Inc. (NYSE: VEEV), a pivotal player in the health information..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 32% Upside with Strong Buy Ratings

Alcon Inc. (NYSE: ALC), a global leader in the eye care sector, emerges as a compelling investment opportunity with a significant upside potential. Headquartered in Geneva,..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Potential 23.43% Upside Beckons Investors

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, particularly in drug manufacturing, continues to be a focal point for investors who are..

Novo Nordisk A/S (NVO) Stock Analysis: Navigating a Healthcare Giant with a 10.55% Potential Upside

Novo Nordisk A/S (NYSE: NVO), a leading name in the global healthcare sector, continues to capture investor attention with its robust business model and strategic initiatives...

Stryker Corporation (SYK) Stock Analysis: Exploring a 16.68% Potential Upside Amidst Strong Revenue Growth

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector and a key player in the medical devices industry, presents an intriguing opportunity for investors seeking..

GSK plc (GSK) Stock Analysis: Evaluating Growth Opportunities in the Healthcare Sector

GSK plc (GSK), a stalwart in the healthcare sector, offers a compelling opportunity for investors seeking exposure to the drug manufacturing industry. With a market capitalization..

Danaher Corporation (DHR) Stock Analysis: Unlocking a 31.76% Potential Upside for Investors

Danaher Corporation (NYSE: DHR), a heavyweight in the healthcare sector with a primary focus on diagnostics and research, offers a compelling opportunity for investors seeking growth..

Eli Lilly (LLY) Stock Analysis: A 22% Upside Potential Amidst Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor attention with its remarkable performance and promising future outlook. With..

AstraZeneca PLC (AZN) Stock Analysis: Strong Buy Ratings and an 18.45% Potential Upside

AstraZeneca PLC (NASDAQ: AZN), a titan in the healthcare sector, specifically within the drug manufacturers industry, boasts a commanding presence with a market capitalization of $228.69..

McKesson Corporation (MCK) Stock Analysis: Impressive Growth Potential with a 9% Upside

In the fast-evolving healthcare sector, McKesson Corporation (NYSE: MCK) stands as a formidable player with a robust market capitalization of $94.6 billion. As a leader in..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring a Promising 11.68% Upside Potential

Gilead Sciences, Inc. (NASDAQ: GILD), a stalwart in the healthcare sector, has captured the attention of investors with its robust portfolio and promising potential upside. With..

Boston Scientific Corporation (BSX) Investor Outlook: Analyzing a 26.82% Potential Upside

Boston Scientific Corporation (NYSE: BSX) has established itself as a formidable presence in the healthcare sector, specifically within the medical devices industry. With a substantial market..

Genuit acquires Davidson Holdings for £49m to expand plumbing and heating portfolio

Genuit Group plc has acquired Davidson Holdings Limited, owner of brands including Salamander Pumps, Cistermiser, Talon and Keraflo, for £49m on a debt-free, cash-free basis. Davidson..

CMC Markets extends partnership with Westpac for online share trading

CMC Markets Stockbroking has been selected as the preferred vendor for Westpac’s online share trading services, covering Westpac Share Trading and St.George Directshares...

GSK Plc names Luke Miels as CEO Designate, effective January 2026

GSK has announced the appointment of Luke Miels as CEO Designate, with full responsibilities and a Board position from 1 January 2026. Currently Chief Commercial Officer,..

Berkeley Group appoints Neil Eady as Chief Financial Officer

Berkeley Group has announced the appointment of Neil Eady to its board as Chief Financial Officer. Neil, who joined Berkeley in 2013, has held several senior..

Silverbullet delivers 10% revenue growth in H1 2025 with strong AI momentum

Silverbullet has reported interim results for the six months to 30 June 2025, with revenue rising 10% to £4.8m and gross profit up to £3.8m. Bookings..
Search

Funds

September 29, 2025

Genuit acquires Davidson Holdings for £49m to expand plumbing and heating portfolio

Genuit Group plc has acquired Davidson Holdings Limited, owner of brands including Salamander Pumps, Cistermiser, Talon and Keraflo, for £49m on a debt-free, cash-free basis. Davidson is expected to generate £32.8m in 2025 revenue and will join Genuit’s Sustainable Building Solutions unit...

CMC Markets extends partnership with Westpac for online share trading

CMC Markets Stockbroking has been selected as the preferred vendor for Westpac’s online share trading services, covering Westpac Share Trading and St.George Directshares...

GSK Plc names Luke Miels as CEO Designate, effective January 2026

GSK has announced the appointment of Luke Miels as CEO Designate, with full responsibilities and a Board position from 1 January 2026. Currently Chief Commercial Officer, Luke has been key in expanding GSK’s specialty medicines and vaccines portfolio, bringing senior experience from AstraZeneca, Roche and Sanofi-Aventis...

Berkeley Group appoints Neil Eady as Chief Financial Officer

Berkeley Group has announced the appointment of Neil Eady to its board as Chief Financial Officer. Neil, who joined Berkeley in 2013, has held several senior finance roles within the Group, including his work on establishing the St William joint venture...

Silverbullet delivers 10% revenue growth in H1 2025 with strong AI momentum

Silverbullet has reported interim results for the six months to 30 June 2025, with revenue rising 10% to £4.8m and gross profit up to £3.8m. Bookings of £9.0m by August nearly matched the full-year 2024 total, supported by new contracts with Apple, Thomson Reuters, Sky Bet and Global Fashion...
Search

Funds

September 29, 2025

FTSE 100

Funds